Shiroyama, T., Suzuki, H., Tamiya, M., Tamiya, A., Tanaka, A., Okamoto, N., . . . Hirashima, T. (2017). Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab‐treated patients with advanced non–small cell lung cancer. Cancer Med.
Chicago Style aipamenaShiroyama, Takayuki, et al. "Pretreatment Advanced Lung Cancer Inflammation Index (ALI) for Predicting Early Progression in Nivolumab‐treated Patients With Advanced Non–small Cell Lung Cancer." Cancer Med 2017.
MLA aipamenaShiroyama, Takayuki, et al. "Pretreatment Advanced Lung Cancer Inflammation Index (ALI) for Predicting Early Progression in Nivolumab‐treated Patients With Advanced Non–small Cell Lung Cancer." Cancer Med 2017.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.